Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line

Journal of Neurochemistry

Volumn 74, Issue 2, 2000, Pages 633-640

  Yoshioka, Akira ^a   Yamaya, Yoko ^a   Saiki, Shinji ^a   Kanemoto, Masumi ^a   Hirose, Genjiro ^a   Pleasure, David ^a,b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Ca2+ influx; Cyclic GMP; Cyclic GMP dependent protein kinase; Non NMDA glutamate receptors; Oligodendroglia; Protein phosphatases

Indexed keywords

8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIBUTYRYL CYCLIC GMP; FORSKOLIN; GUANYLATE CYCLASE; IBUDILAST; ISOBUTYLMETHYLXANTHINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; OKADAIC ACID; PHOSPHODIESTERASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROPENTOFYLLINE; ROLIPRAM;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; STEM CELL; WESTERN BLOTTING;

ANIMALS; CALCIUM; CELL LINE, TRANSFORMED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; EXCITATORY AMINO ACID AGONISTS; ISOENZYMES; KAINIC ACID; NEUROTOXINS; OLIGODENDROGLIA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033979856     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.740633.x     Document Type: Article

References (50)

1. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
2. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
3. Butt E., Van Bemmelen M., Fischer L., Walter U., and Jastorff B. (1990) Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS Lett. 263, 47-50.
4. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Crepel F. and Jaillard D. (1990) Protein kinase, nitric oxide and long-term depression of synapses in the cerebellum. Neuroreport 1, 133-136.
6. Desole M. S., Kim W.-K., Rabin R. A., and Laychock S. G. (1994) Nitric oxide reduces depolarization-induced calcium influx in PC12 cells by a cyclic GMP-mediated mechanism. Neuropharmacology 33, 193-198.
7. De Vente J., Manshanden C. G., Sikking R. A., Ramaekers F. C. S., and Steinbusch H. W. M. (1990) A functional parameter to study heterogeneity of glial cells in rat brain slices: cyclic guanosine monophosphate production in atrial natriuretic factor (ANF)-responsive cells. Glia 3, 43-54.
8. El-Husseini A., Bladen C., and Vincent S. R. (1995) Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J. Neurochem. 64, 2814-2817.
9. Forloni G., Lucca E., Angeretti N., Chiesa R., and Vezzani A. (1997) Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J. Neurochem. 68, 319-327.
10. Furukawa K. and Mattson M. P. (1998) Secreted amyloid precursor protein selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83, 429-438.
11. Gamm D. M., Francis S. H., Angelotti T. P., Corbin J. D., and Uhler M. D. (1995) The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms. J. Biol. Chem. 270, 27380-27388.
12. Garthwaite G. and Garthwaite J. (1988) Cyclic GMP and cell death in rat cerebellar slices. Neuroscience 26, 321-326.
13. Giulian D., Vaca K., and Corpuz M. (1993) Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
14. Husain J. and Juurlink B. H. J. (1995) Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res. 698, 86-94.
15. Ito M. and Karachot L. (1990) Messengers mediating long-term desensitization in cerebellar Purkinje cells. Neuroreport 1, 129-132.
16. Jaffrey S. R. and Snyder S. H. (1995) Nitric oxide: a neural messenger. Annu. Rev. Cell Dev. Biol. 11, 417-440.
17. Jarchau T., Häusler C., Markert T., Pöhler D., Vandekerckhove J., De Jonge H. R., Lohmann S. M., and Walter U. (1994) Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc. Natl. Acad. Sci. USA 91, 9426-9430.
18. Keller B. U., Hollmann M., Heinemann S., and Konnerth A. (1992) Calcium influx through subunits GluR1/GluR3 of kainate/AMPA receptor channels is regulated by cAMP dependent protein kinase. EMBO J. 11, 891-896.
19. Koh J. Y. and Choi D. W. (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83-90.
20. Laemmli U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
21. Leifer D., Buonanno F. S., and Richardson E. P. Jr. (1990) Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology 40, 911-918.
22. Lincoln T. M. and Cornwell T. L. (1993) Intracellular cyclic GMP receptor proteins. FASEB J. 7, 328-338.
23. Louis J. C., Magal E., Muir D., Manthorpe M., and Varon S. (1992) CG-4, a new bipotential glial cell line from rat brain is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31, 193-204.
24. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., and Fagni L. (1992) Nitric oxide-induced blockade of NMDA receptors. Neuron 8, 653-662.
25. Matute C., Sanchez-Gomez M. V., Martinez-Millan L., and Miledi R. (1997) Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA 94, 8830-8835.
26. McDonald J. W., Althomsons S. P., Hyrc K. L., Choi D. W., and Goldberg M. P. (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4, 291-297.
27. McMahon D. G. and Ponomareva L. V. (1996) Nitric oxide and cGMP modulate retinal glutamate receptors. J. Neurophysiol. 76, 2307-2315.
28. 2+ current modulated by cGMP-dependent protein kinase. Nature 369, 336-339.
29. Meskini N., Nemoz G., Okyayuz-Baklouti I., Lagarde M., and Prigent A.-F. (1994) Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 47, 781-788.
30. Mitrovic B., Ignarro L. J., Vinters H. V., Akers M.-A., Schmid I., Uittenbogaart C., and Merrill J. E. (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65, 531-539.
31. Nakazawa K., Mikawa S., Hashikawa T., and Ito M. (1995) Transient and persistent phosphorylation of AMPA-type glutamate receptor subunits in cerebellar Purkinje cells. Neuron 15, 697-709.
32. Patneau D. K., Wright P. W., Winters C., Mayer M. L., and Gallo V. (1994) Glial cells of the oligodendrocyte lineage express both kainate-and AMPA-preferring subtypes of glutamate receptor. Neuron 12, 357-371.
33. Pende M., Holtzclaw L. A., Curtis J. L., Russell J. T., and Gallo V. (1994) Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc. Natl. Acad. Sci. USA 91, 3215-3219.
34. Prineas J. W., Barnard R. O., Kwon E. E., Sharer L. R., and Cho E. S. (1993) Multiple sclerosis - remyelination of nascent lesions. Ann. Neurol. 33, 137-151.
35. Raine C. S. and Wu E. (1993) Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52, 199-204.
36. Schlichter D. J. (1982) Cyclic GMP-dependent protein phosphorylation in mammalian cerebellum. Prog. Brain Res. 56, 105-123.
37. Shibuki K. and Okada D. (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349, 326-328.
38. Souness J. E., Villamil M. E., Scott L. C., Tomkinson A., Giembycz M. A., and Raeburn D. (1994) Possible role of cyclic AMP phosphodiesterase in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Br. J. Pharmacol. 111, 1081-1088.
39. Tanaka J., Markerink-van Ittersum M., Steinbusch H. W., and De Vente J. (1997) Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia 19, 286-297.
40. Tang W., Paulding W. R., and Sumners C. (1993) ANP receptors in neurons and astrocytes from spontaneously hypertensive rat brain. Am. J. Physiol 265, C106-C112.
41. Thorburne S. K. and Juurlink B. H. J. (1996) Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 67, 1014-1022.
42. Towbin H., Staehelin T., and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
43. Wang X. and Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443-456.
44. Weill C. L. and Greene D. P. (1984) Prevention of natural motoneurone cell death by dibutyryl cyclic GMP. Nature 308, 452-454.
45. Wender M. and Szczech J. (1994) Myelin-oligodendroglia complex in rats subjected to experimental cardiac arrest. Exp. Toxicol. Pathol. 46, 477-481.
46. Yoshioka A., Hardy M., Younkin D. P., Grinspan J. B., Stern J. L., and Pleasure D. (1995) α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J. Neurochem. 64, 2442-2448.
47. Yoshioka A., Ikegaki N., Williams M., and Pleasure D. (1996a) Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell lines. J. Neurosci. Res. 46, 164-172.
48. Yoshioka A., Bacskai B., and Pleasure D. (1996b) Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 46, 427-437.
49. Yoshioka A., Shimizu Y., Hirose G., Kitasato H., and Pleasure D. (1998) Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. J. Neurochem. 70, 2416-2423.
50. Younkin D. P., Tang C.-M., Hardy M., Reddy U. R., Shi Q.-Y., Pleasure S. J., Lee V. M.-Y., and Pleasure D. (1993) Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc. Natl. Acad. Sci. USA 90, 2174-2178.